Esperion Therapeutics, Inc. · NASDAQ:ESPR
Vanguard Capital Management LLC reported a 5.08% stake in Esperion Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 31, 2026
Vanguard Capital Management LLC reported a 5.08% stake in Esperion Therapeutics, Inc., 13,105,104 shares, as a passive investor on Jun 30, 2026. Filed Jul 31, 2026 (Schedule 13G).
- Stake
- 5.08%
- Shares
- 13,105,104
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.08% | 13,105,104 |
Source
Related
- Esperion Therapeutics, Inc.
- Vanguard Capital Management LLC
- Esperion Therapeutics, Inc. shareholders
- Schedule 13G · Goldman Sachs Group Inc · Aug 13, 2026
- Schedule 13G/A · Wasatch Advisors LP · Jul 14, 2026
- Form 4 · Hoffman Robert E. · Jul 13, 2026
- Form 4 · Carroll J Martin · Jul 13, 2026
- Form 4 · Shepard Jay · Jul 13, 2026